Day: June 20, 2024

PALO ALTO, Calif., June 20, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that in anticipation of selling our commercially available products to new and current special customers, Scilex has entered into a non-exclusive distribution agreement with a well-known and highly respected distributor with over 10 years of sales excellence, Endeavor Distribution LLC. (“Endeavor”). Endeavor has logistics expertise to sell and distribute our currently marketed non-opioid products nationally. Endeavor is an Oklahoma-owned and operated company committed to top-notch logistics and distribution service. They have...

Company has committed capital in excess of $250 million Fleet customer pipeline includes Yale University, Princeton University, UCLA, Enterprise Fleet Services, DB Schenker and Mobile Road Service Solutions, a AAA provider The Company is also planning to deploy vehicles to Canada with key prospective partners including a major telecom company, which has already tested vehicle telematics with Mullen Mullen’s Class 1 EV cargo van with solid-state polymer battery pack with significant improvement to range will be fully certified for production and sale in second half of 2025 Company in current talks to acquire EV OEMs to expand product portfolio for commercial and passenger EVs Mullen to obtain over-the-air (OTA) vehicle technology powered by AI, along with other related IP assets as part of a successful acquisitionBREA, Calif., June 20,...

NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today released findings from its 2024 LGBTQ+ family building survey. The report, which surveyed over 1,100 LGBTQ+ individuals in the U.S. planning to build their families, highlights the unique challenges LGBTQ+ patients face, including struggles with insufficient access to care, financial constraints, and lack of mental health support throughout their family building journey. Progyny’s survey underscores the pivotal role employers can play in providing inclusive and comprehensive family building benefits that support all paths to parenthood. The findings highlight that employers can significantly improve the lives of LGBTQ+ employees by providing extensive support and resources...

WISeKey Announces Creation QUANTIX EDGE SECURITY Joint Venture with SEALSQ, ODIN Solutions, and TProtege Creates an innovative Cybersecurity and Semiconductor Customization Center, currently in advanced negotiations for PERTE Chip funding with the Spanish GovernmentGeneva, Switzerland / Murcia, Spain – June 20, 2024: In a strategic move that establishes a new milestone in the global cybersecurity and semiconductor landscape, WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY) and its subsidiary SEALSQ Corp (“SEALSQ”) (NASDAQ: LAES), leaders in cybersecurity, artificial intelligence (AI), blockchain, semiconductors, PKI, and post-quantum technology, announced today the signing of an agreement with ODIN Solutions (“ OdinS”) and TProtege, leading companies in Internet of Things (IoT) and security, to create a...

AD04 reduced heavy drinking days among heavy drinking individuals with alcohol use disorder and a specific genetic profile, as identified by a companion diagnostic test (CDx) GLEN ALLEN, Va., June 20, 2024 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced the publication of previously disclosed results from its Phase 3 ONWARD study in a peer-reviewed article in the European Journal of Internal Medicine entitled, “Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypes.” The publication findings showed a significant difference in the monthly percentage of heavy drinking days between the...

FAIRFIELD, N.J., June 20, 2024 (GLOBE NEWSWIRE) — Kearny Financial Corp. (NASDAQ GS: KRNY) (the “Company”), the holding company for Kearny Bank (the “Bank”), announced today that the Board of Directors promoted Keith Suchodolski to Senior Executive Vice President and Chief Operating Officer, effective July 1, 2024. Mr. Suchodolski has held progressive leadership roles within the Company since 2013, most recently serving as Chief Financial Officer since July 2018. In his new role, Mr. Suchodolski’s range of responsibilities will broaden to include strategic oversight of retail & business banking, human resources, marketing, corporate finance and corporate administration. Craig L. Montanaro, President and Chief Executive Officer said, “Keith is an accomplished leader with a track record of success throughout his time with the...

Following FDA Approval to Commence the Clinical Trial, an Official Site Initiation Has Taken Place as Preparation for Patient Enrollment Advances Multiple Robotic Systems Already Received by the Site to Allow Inventory Readiness in Support of Trial BRAINTREE, Mass., June 20, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) announced its agreement with Brigham and Women’s Hospital (BWH), a leading academic medical center located in Boston, Massachusetts, to serve as one of the sites to perform the pivotal human clinical trial for its LIBERTY® Endovascular Robotic Surgical System, as part of its Investigational Device Exemption (“IDE”) application. This development, previously announced on June 17, 2024, follows the U.S. Food and Drug Administration’s approval to commence Microbot’s pivotal human clinical trial. The Company...

Minneapolis, MN, June 20, 2024 (GLOBE NEWSWIRE) — Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, today announced that the Company’s Board of Directors (the “Board”) has authorized the repurchase of an additional $15.0 million of the Company’s common stock after completing its $5.0 million stock repurchase plan announced on December 22, 2023. The manner, timing and amount of any purchase will be based on an evaluation of market conditions, stock price and other factors. “Our confidence in the Company’s continued momentum allows the Board to authorize a new $15 million stock repurchase program,” stated Charlie Youakim, Sezzle Chairman and CEO. “We remain committed to maximizing shareholder value through a disciplined capital allocation policy that will drive growth and maintain...